Skip to main content

Table 2 Left ventricle parameters of CMR in studied children of different sub-types of cardiomyopathy

From: Delayed myocardial enhancement in children with different types of cardiomyopathy: a diagnostic and prognostic tool

Sub-types of cardiomyopathies

LVEF% median (range)

LVEDV (ml) median (range)

LVEDVI median(range)

LVESV (ml) median (range)

LVESVI median (range)

Primary dilated

19.7 (12–54) b, c, d

208.8 (76–412) b, c, d

170.1 (89–338) a, b, c, d

162.9 (53–362) b, c, d

125.5 (41–257) b, c, d

Secondary dilated post myocarditis

29.5 (9–72) e

157 (121–367) e, f

82.6 (70–195) a, e

101.5 (42–327) e

56.7 (23–174) e

Secondary dilated toxins, drugs

43.8 (32–56)

43.4 (32–55)

41 (23–59)

22.8 (22–24)

20.7 (16–26)

Hypertrophic

65 (45–81) b, e

51 (16–172) b, e

75 (21–117) b, e

26.4 (6–59) b, e

26.3 (12–45) b, e

Non-compaction

60 (6–67) c

63 (6–135) c, f

66.3 (15–250) c

24 (3–127) c

56.7 (6–235) c

ARVD

42.3 (53–63)

68.3 (53–84)

73.8 (55–92)

30 (29–32)

32.3 (30–35)

Restrictive

*

*

*

*

*

Infiltrative thalassemia

43.5 (21–66) d

113.8 (16–128) d

110.7 (18–119) d

66 (5–96) d

62.3 (6–94) d

Infiltrative others

70.2 (69–72) d

79.5 (26–134) d

63.6 (56–71) d

23 (8–38) d

18.9 (18–20) d

Ischemic

40.5 (35–46)

137.5 (19–256)

86.6 (41–132)

75.2 (12–138)

49 (27–71)

Test of significance

24.7

21.7

22.2

24.9

22.3

p value

0.006*

0.016*

0.014*

0.005*

0.013*

  1. Similar letters indicate significant difference